Navigation Links
TriLink BioTechnologies Awards Keck Science Department ResearchReward
Date:3/7/2013

SAN DIEGO, March 7, 2013 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink, trilinkbiotech.com) has granted Dr. Aaron Leconte of the WM Keck Science Department of Claremont McKenna , Pitzer and Scripps Colleges a ResearchReward for mutant polymerase research.

"The use of DNA biotechnologies is often limited by which DNA polymerases recognize which modified nucleotide analogs," stated Dr. Leconte. "In my lab, we are working on discovering DNA polymerases with novel substrate recognition to expand the usefulness of modified nucleotides.  TriLink is one of the leaders in the synthesis of high-quality, novel nucleotide analogs, and this ResearchRewards grant enables us to work on a significantly more diverse set of nucleotide analogs," concluded Dr. Leconte.

"We are pleased that TriLink's modified nucleotide analogs and custom oligonucleotides help advance directed enzyme evolution," commented Richard Hogrefe , CEO of TriLink. "TriLink continues to expand its portfolio of nucleotide analogs to support researchers like Dr. Leconte, as they push the envelope of science."

TriLink has been proud to support research and education with its ResearchReward Program, since the program's inception in 2002. Over 35 grants have been awarded for research including nucleotide selectivity of error prone RNA viral polymerases, PCR primer design for undergraduate teaching and research, CleanAmp™ Primers for detection of mRNA expression and DNA repair studies of cross-linked DNA.

About TriLink's ResearchRewards Program
TriLink offers ResearchRewards to help offset the cost of nucleic acid-based products to support educators and researchers. Applicants will be notified of the review results within 2 months. To download an application or learn more visit www.trilinkbiotech.com/about/researchrewards.asp.

About TriLink
TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the diagnostic and OEM markets. In addition, custom chemistry, long RNA transcript synthesis and contract research services and ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 50 scientists and other professionals. For more information about the firm and products, visit our web site at trilinkbiotech.com.

Contact: 
Angela Tenenini 
marketing@trilinkbiotech.com


'/>"/>
SOURCE TriLink BioTechnologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. OPX Biotechnologies Selected as Innovation Pioneer at IHS CERAWeek
2. Adaptive Biotechnologies launches clonoSEQ, a more sensitive, accurate assay to detect minimal residual disease (MRD) in blood-based cancers.
3. Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
4. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
5. Leading Scientists to Debate Views on Rejuvenation Biotechnologies
6. Young Pathologists Receive Awards for Research
7. National Non-Profit Awards Audio Conferencing to SoundConnect
8. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
9. Nerium Recaps the 44th Annual NAACP Image Awards
10. Molecular Medicine Awards 1st Annual Ross Prize to NYU Researcher
11. Taylor-Wharton CryoScience 'Partners For Life' Awards Liquid Nitrogen Freezer to Comprehensive Cancer Center at University of Alabama at Birmingham
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
Breaking Biology Technology:
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
Breaking Biology News(10 mins):